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Abstract
In a sample of 3,187 twins and 3,294 of their parents, we sought to investigate association of both individual variants and a
genotype-based height score involving 176 of the 180 common genetic variants with adult height identified recently by the
GIANT consortium. First, longitudinal observations on height spanning pre-adolescence through adulthood in the twin
sample allowed us to investigate the separate effects of the previously identified SNPs on pre-pubertal height and pubertal
growth spurt. We show that the effect of SNPs identified by the GIANT consortium is primarily on prepubertal height. Only
one SNP, rs7759938 in LIN28B, approached a significant association with pubertal growth. Second, we show how using the
twin data to control statistically for environmental variance can provide insight into the ultimate magnitude of SNP effects
and consequently the genetic architecture of a phenotype. Specifically, we computed a genetic score by weighting SNPs
according to their effects as assessed via meta-analysis. This weighted score accounted for 9.2% of the phenotypic variance
in height, but 14.3% of the corresponding genetic variance. Longitudinal samples will be needed to understand the
developmental context of common genetic variants identified through GWAS, while genetically informative designs will be
helpful in accurately characterizing the extent to which these variants account for genetic, and not just phenotypic,
variance.
Citation: Vrieze SI, McGue M, Miller MB, Legrand LN, Schork NJ, et al. (2011) An Assessment of the Individual and Collective Effects of Variants on Height Using
Twins and a Developmentally Informative Study Design. PLoS Genet 7(12): e1002413. doi:10.1371/journal.pgen.1002413
Editor: Greg Gibson, Georgia Institute of Technology, United States of America
Received July 18, 2011; Accepted October 25, 2011; Published December 8, 2011
Copyright:  2011 Vrieze et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Support was provided by grants R37 DA05147, R01 AA09367, R01 AA11886, R01 DA13240, U01 DA024417 and 5T32 MH017069 (SIV). NJS is supported
in part by the following National Institutes of Health research grants: U19 AG023122-01, R01 MH078151-01A1, N01 MH22005, P50 MH081755-01, UL1 RR025774,
RC2 DA029475, R01 AG031224, U54 NS056883, as well as the Price Foundation and Scripps Genomic Medicine. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: vrie0006@umn.edu
Introduction
Adult height is a model multigenic phenotype for genetic
association studies. Twin and adoption studies suggest that height
is highly heritable (,80%) [1,2,3], but the identification of
individual genetic variants that contribute large effects to normal-
range adult height (as with most complex traits) has proven to be
very difficult [4,5]. Despite this, it does appear possible that
common SNPs with individually small effects can account for a
large proportion of phenotypic variance in adult height (,45%)
[6] and may be identified with appropriately large sample sizes. To
that end, the GIANT consortium has identified 180 SNPs that
collectively account for 10.5% of variance in adult height in a
sample of 183,727 individuals [7].
For any person adult height reflects roughly two decades of
growth. Change in height is relatively rapid throughout infancy,
slows down in early childhood, and increases again during puberty
when a notable growth spurt occurs [8,9]. The heritability of
growth during any particular developmental period appears to be
high, and it has been shown that some genetic variants affect a
substantial proportion of height’s phenotypic variance throughout
development. For example, a longitudinal study of Swedish male
twins found a genetic correlation of 0.73 between height at age 2
and at age 18, suggesting that 53% of the genetic variance in
height at these ages is shared [10]. In contrast to this genetic
consistency, the same study found that height measured during the
pubertal growth spurt (ages 11 to 17) to be most influenced by new
genetic variation. This differential effect of individual genetic
variants on different stages of growth remains largely to be
investigated, and the present study is a step in that direction. To
accomplish this, we evaluated the relative effect of the SNP
variants identified by [7] as part of the GIANT consortium efforts
on both prepubertal height and growth during puberty.
Materials and Methods
The sample (N=6481) was drawn from Caucasian participants
in the Minnesota Twin Family Study (MTFS). The MTFS a 20-
year, longitudinal, community-representative study conducted at
the University of Minnesota and approved by the University of
Minnesota Institutional Review Board continuously since incep-
tion. The study has been extensively described previously [11].
The sample is composed of two cohorts of families. Twins in the
younger cohort (N=2046) were born between 1977 and 1994.
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youngest any individual was evaluated was at age 10.75). Twins
in the older cohort (N=1141) were born between the years 1972
and 1979 and were initially evaluated at approximately age 17.
Both cohorts were followed-up at approximately three- to five-year
intervals, with assessments thus targeting ages 11, 14, 17, 21, 24,
and 29 years of age. Height was measured in a laboratory setting
during visits to the University of Minnesota. Means and standard
deviations for each twin’s height and age of assessment at each
wave are given in Table 1. Change in height is most rapid from
age 11 to 14, with girls tapering off before boys, consistent with an
earlier pubertal onset for girls [12]. Parents of the twins were also
evaluated. There were 1332 fathers born between 1926 and 1976
with a mean height of 178.11 cm (SD=6.51 cm). There were
1962 mothers born between 1934 and 1976 with a mean height of
165.03 cm (SD=5.94 cm).
The twin sample was used to develop a genetically mediated,
longitudinal growth model for height. There are many approach-
es to analysis of longitudinal designs, and choosing the best
approach often requires assumptions about, or explicit knowledge
of, the (unknown) true growth trajectories generating the data
[13]. Choosing a model for our sample was greatly facilitated by
our ability to simultaneously leverage longitudinal measurements
and twin zygosity information. We chose to model longitudinal
height variability via a mixed model [14], because it could
accommodate an intuitive variance-component decomposition to
model growth through random intercept and random slope terms
(i.e., the random effects). Covariates and SNPs were included in
the model as fixed effects. We also accounted for twin zygosity by
partitioning the random intercept and slope into additive genetic,
shared environment, and unshared environmental effects using
standard biometric twin methods [15]. Throughout the remain-
der of this paper we refer to this model simply as a ‘growth
model.’
The growth model was constructed on the twins to evaluate
SNP effects on age-11 height and pubertal growth after age 11. In
the growth model, age-11 height corresponds to the intercept and
pubertal growth corresponds to the slope. A diagram of the model
is depicted in Figure 1. The full phenotypic diagram is portrayed.
An extension to twins is included in the box inset.
In the path diagram of the phenotypic model (Figure 1) the
observed measurements of height are represented by squares, one
square for each height measurement taken (age 11, 14, 17, etc.).
These measures are assumed to be a function of three random
effects: one capturing variation in the intercept, one capturing
variation in the slope, and one capturing variation in a residual
effect. The intercept and slope variances were freely estimated.
Covariate effects were treated as fixed effects. All height measures
were centered at 10.75, the youngest age at which any participant
was assessed (the mean age of the first assessment was 11.85). The
intercept loads equally onto all height measurements, and is
interpretable as height at (roughly) age 11. The slope reflects an
individual’s change in height from age 11 to adulthood. Loadings
on the slope factor were fixed at each individual’s actual age at
assessment and so took into account the variation in age that
existed at each assessment.
An important caveat with the proposed growth model as
described in Figure 1 is its linear form. Growth in height is known
to be nonlinear—growth velocity tapers during late adolescence
and subsequently asymptotes. To account for this, without
introducing a quadratic term, we used a piecewise linear
approach. Consistent with previous literature [9], males were
assumed to stop growing at any appreciable rate at age 18.
Females were assumed to cease growing at age 16. These
constraints were implemented by fixing all ages of assessment



















Age 11 1016 327 168 11.78 (.40) 150.09 (7.80) 1012 315 179 11.76 (.45) 151.64 (7.68)
Age 14 880 281 146 14.85 (.48) 170.90 (8.19) 892 273 159 14.82 (.54) 163.79 (6.22)
Age 17 1170 371 196 17.71 (.51) 177.78 (6.74) 1320 425 218 17.75 (.59) 164.97 (6.32)
Age 20 916 287 142 21.31 (.86) 178.88 (6.65) 1126 348 195 20.76 (.56) 165.50 (6.35)
Age 24 817 242 130 24.72 (.96) 178.95 (6.61) 509 154 90 25.05 (.60) 166.42 (6.46)
Age 29 728 210 116 29.45 (.54) 179.17 (6.58) 566 178 85 29.49 (.51) 165.51 (6.17)
MZ is monozygotic twin; DZ is dizygotic.
doi:10.1371/journal.pgen.1002413.t001
Author Summary
We evaluated the developmental specificity of 176 SNPs
known to affect adult height based on meta-analysis from
the GIANT consortium. First, longitudinal observations on
height spanning pre-adolescence through adulthood in a
twin sample allowed us to investigate the individual
effects of the previously identified SNPs on both pre-
pubertal height and pubertal growth spurt. We show that
the effect of the SNPs identified by the GIANT consortium
is primarily on prepubertal height. Only one SNP,
rs7759938 in LIN28B, approached a significant association
with pubertal growth. Second, using standard twin
heritability models, we investigated the extent to which
the collective effect of these SNPs explained genetic
variance in height—as opposed to phenotypic variance, as
other studies have done. We computed a genetic score by
weighting SNPs according to their effects as assessed via
meta-analysis. We show that, while the score accounts for
,9% of the phenotypic variance in height (i.e., the overall
variance), it accounts for ,14% of the corresponding
genetic variance. Longitudinal samples are necessary to
understand the developmental context of common
genetic variants identified through GWAS, while twin
samples will be helpful in accurately characterizing the
extent to which these variants account for genetic, and not
just phenotypic, variance.
Developmental Approach to SNP Effects on Height
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assessment greater than 16 to be 16 in females.
As portrayed in Figure 1, the model allows one to test the effect
of a SNP directly on the intercept (age 11 height) and slope
(pubertal growth). This technique avoids multiple testing on each
individual age of assessment (the square boxes) and carries all the
advantages that come with the mixed model/variance compo-
nents approach (e.g., full-information maximum likelihood
estimation, increased precision in estimating the intercept and
slope, etc. [14]).
Analogous to the phenotypic growth model is the twin growth
model, partially displayed in the box inset in Figure 1. Here we see
that the intercept and growth random effects can, with the use of
twins, be further partitioned into three sources of variance:
additive genetic variance (A), shared environmental variance (C),
and unshared environmental variance (E). The SNP effect can
Figure 1. Diagram of the Piecewise Linear Growth Model. Measurements of height were taken at approximately ages 11, 14, 17, 20, 24, and
29. The measurements are adjusted for covariates, and then modeled as a function of a random intercept, representing age-11 height, and a random
slope, representing growth in height from age 11 to adulthood, and a residual, which for convenience of presentation is not depicted in the figure.
The intercept and the slope are allowed to correlate (this is represented as the double-headed arrow connecting them). The loadings of the slope
onto height (denoted a11–a29) are the ages of participants during each of the assessments. The slope is piecewise linear in age, with the maximum
age constrained to be 18 in males and 16 in males (see text for details). The effect of a SNP on the intercept and slope (denoted bi and bs,
respectively) can be estimated directly. The growth model extension to twins is portrayed in the inset box. By taking advantage of twin zygosity, the
variance in the intercept and slope are partitioned into additive genetic (A), shared environmental (C), and unshared environmental (E) components.
The correlation between the intercept and slope can also be decomposed in this way (e.g., rg would be the genetic correlation, rc would be the
shared environmental correlation, etc.). Using twins in this way, one can model the effect of a SNP onto the additive genetic variance in the intercept
and slope, instead of merely the overall phenotypic variance. These effects are denoted as big and bsg, respectively.
doi:10.1371/journal.pgen.1002413.g001
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controlling for environmental noise in the phenotype.
With the proposed growth model, we could estimate the effect
of SNPs on the intercept (i.e., height at age 10.75, the earliest age
at which any participant was assessed) and slope (i.e., pubertal
growth). Using twins, we could further estimate the influence of
SNP effects on genetic variance—as opposed to overall phenotypic
variance—thus providing a direct estimate of the genetic variance
accounted for by the SNPs. Studies on height heretofore have been
unable to accomplish this, and have been restricted to comparing
estimates of the percent of variance accounted for by SNPs in their
sample to estimates of heritability obtained in separate studies of
twins (e.g., as in refs [6,7,16]).
There is considerable variation in age of pubertal onset. To
obtain a more accurate measure of pubertal age (versus
chronological age) we used the Pubertal Development Scale [17]
for the age-11 and age-14 assessments. These measures were self-
report items written to reflect Tanner stages, such as pubic hair
and voice changes (in males), breast development, menarche, and
skin changes (in girls). Each item is measured on a four-point scale
and reliability/validity has been found to be acceptable [17]. For
each sex, items were averaged to form overall puberty scores for
each individual. These scores, and their correlations with height
and age at the age-11 and age-14 assessments, are reported in
Table 2. According to the mean differences and correlation
patterns, the females are further along in pubertal self-ratings than
boys at the age-11 assessment. The girl’s puberty score is also more
highly correlated with height during the age-11 assessment than
the age-14 assessment, indicating an early pubertal growth spurt in
girls. The reverse is true for males, their puberty score has a low
correlation with height at age 11 and a higher correlation at age
14, indicating a later pubertal growth spurt. At the age-11
assessment 15% of females had experienced menarche, versus
93% by the age-14 assessment. Average age of menarche was 12.8
years (SD=1.0)
We incorporated pubertal status into the growth model in the
following way. For each age of assessment we regressed height on
age and puberty score and, for females, an indicator variable
measuring whether menarche had occurred by that assessment.
For males both age and puberty score were highly significant in
predicting height at age 11 (r
2=.17, p,2e
216) and 14 (r
2=.23,
p,2e
216). In females at age 11 age, puberty score, and menarche
significantly predicted height (r
2=.32, p,2e
216). At age 14 only
the puberty score was a significant predictor (r
2=.04, p=8.4e
29).
We computed the sum of age and puberty score (and menarche for
females) weighted by their corresponding regression weight and
scaled the result to have the mean and variance of the original
chronological age at 11 and 14. This gives an estimate of each
subject’s pubertal age—as opposed to chronological age—as it
relates to growth in height. In supplementary analyses these
pubertal ages were used in place of chronological age for the age-
11 and age-14 assessments in the growth model, in an attempt to
more precisely gauge the developmental specificity of each SNP.
All statistical analysis was conducted in the R Environment
[18]; growth models were fit via maximum likelihood with the
OpenMx package [19]. R scripts that implement the models used
in this paper are available upon request.
Genotyping and Imputation
SNPs were genotyped on an Illumina 660quad array using
DNA derived from whole blood for approximately 90% of the
sample and from saliva samples for the remainder. For quality
control purposes, each 96-well plate included DNA from two
members of a single CEPH family (rotated across plates) and one
duplicate sample. Markers were excluded if (see ref [20] for
additional details): 1) they had been identified as a poorly
genotyped marker by Illumina; 2) had more than one mismatch
in duplicated QC samples; 3) had a call rate ,99%; 4) had a MAF
,1%; 5) had more than 2 Mendelian inconsistencies across
families; 6) significantly deviated from Hardy-Weinberg equilib-
rium at p,1e-7; 7) was an autosomal marker but associated with
sex at p,1e-7; 8) had a significant batch effect at p,1e-7; or 8)
there were more than 2 heterozygous X chromosome calls for
males or mitochondrial calls for anyone. In total, 32,153 (5.7%) of
the 559,982 SNP markers were eliminated by these screens, with
the majority (3.6%) being eliminated because of low MAF.
Samples were eliminated if: 1) they had .5000 no-calls; 2) had a
low GenCall score; 3) had extreme heterozygosity or homozygos-
ity; or 4) represented a sample mix-up or we could not confirm
known genetic relationships. In total, 160 (2.2%) of the total
genotyped sample of 7438 failed one or more of these criteria, with
the majority (1.7%) failing because of low call rate.
Of the 180 SNPs described by the GIANT consortium as
associated with height, 52 existed on the Illumina 660quad. The
remaining were imputed with best-guess genotypes using MaCH
[21,22] and haplotypes from the 1000 Genomes 2010-06 reference
dataset. Of the 128 imputed SNPs, three had poor imputation
quality (rs17511102, rs11144688, rs473902; r
2=.08, .46, and .20).
One SNP (rs5017948) was not contained in the 1000 Genomes
2010-06 or 2010-08 reference datasets and so was discarded. The
average r
2 of the remaining 124 imputed SNPs was .96 (SD=.07,
range=[.55, 1.0]). In total, 176 of the 180 SNPs from the GIANT
Consortium meta-analysis [7] were available in the current
dataset. A genetic score was created by summing these 176 SNPs,
weighted by their individual meta-analytic regression coefficient
reported in the GIANT Consortium report [7]. All analyses
Table 2. Measures of Pubertal Status.
Age of Assessment Mean Median SD Correlation with age at that assessment Correlation with height at that assessment
Males
Age-11 Puberty 1.3 1.3 0.49 0.21 0.28
Age-14 Puberty 2.7 2.8 0.58 0.35 0.47
Females
Age-11 Puberty 2.2 2.3 0.64 0.28 0.51
Age-14 Puberty 3.3 3.3 0.44 0.28 0.21
Pubertal stage as measured by a self-report questionnaire inquiring about Tanner stages of pubic and body hair growth, voice changes in boys, and breast development
and menarche in girls. Responses (except for menarche) are recorded on a four-point scale (1–4).
doi:10.1371/journal.pgen.1002413.t002
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status (younger versus older), and the 10 first principal components
from Eigenstrat [23] based on a subsample of 10,000 SNPs from
sample founders (i.e., unrelated subjects).
Results
First, we ran association tests for each of the 176 SNPs on adult
height in the full sample. A subset of twins (N=775) had not yet
reached adult height and were excluded from this analysis (i.e.,
were male and under 18 at the time of their last assessment, or
were female and under 16). To account statistically for within-
family clustering a generalized least squares method was used [24].
One-tailed test results are displayed in Figure 2. A few trends are
clear. First, there was insufficient power in the present sample
(N=5706) to detect a genome-wide significant association for
many SNPs. This was not surprising because 185,000 subjects
were required in the GIANT Consortium [7] to reliably identify
these SNPs. Six SNPs were significant at the Bonferroni correction
for 176 tests at alpha of .05. Ninety-eight of the 170 SNPs were
nominally statistically significant at .05. Despite a lack of genome-
wide or Bonferroni significance, it was clear from the QQ plot that
the vast majority of SNPs had lower p-values than expected by
chance. This was clearly true for the genetic score based on the
176 SNPs, which was highly significant (p=4e
2102) and accounted
for 9.2% (95% confidence interval=[8.2%, 11.1%]) of the
phenotypic variance in adult height (in the full sample
N=5706). This result is not significantly different from the r
2 of
10.5% found by the GIANT Consortium in [7]. As described in
detail later, this same SNP score accounted for 14.3% (95%
Figure 2. SNP and Genetic Score Effects for Adult Height. On the left panel are the univariate associations for each of the 176 SNPs (of the 180
SNPs from the Allen et al. [7] meta-analysis) ordered by chromosomal location along the x-axis. On the right is the same information portrayed in a
QQ plot. . Note the discontinuous y-axis. Filled circles represent SNPs with direction of effect equal to that reported in the meta-analysis. ‘‘+’’ symbols
represent SNPs with effects opposite to that reported in the meta-analysis. The filled triangle represents the genetic score. All p-values are also
reported in Table S1. SNPs in Figure 2 and Figure 3 are colored to faciliatate cross-referencing between panels and between figures.
doi:10.1371/journal.pgen.1002413.g002
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as estimated in the twin sample alone.
Fitting the growth model, we found the intercept was 86%
heritable (95% c.i.=[69%, 100%]) and the slope 84% heritable
(65%, 100%). Shared environmental effects accounted for 9%
(0%, 27%) and 11% (0%, 31%) of the variance in the intercept
and slope, respectively. Unshared environment accounted for 5%
(4%, 6%) in the intercept and 5% (4%, 7%) in the slope. Clearly,
both age-11 height and pubertal growth (here, the intercept and
slope) were highly heritable, consistent with previous reports [2].
The total phenotypic correlation between age-11 height and
pubertal growth of 2.62 indicates that taller individuals at age 11
experienced less growth after age 11. The genetic correlation
between age-11 height and pubertal growth was 2.56 (2.70,
2.41), indicating that only 31% of genetic effects on age-11 height
and pubertal growth are shared. Shared and non-shared
environmental correlations were negligible (2.03 and 2.03,
respectively, both non-significant).
Individual SNP and genetic score effects on the intercept and
slope were computed simultaneously. Log-transformed p-values
are displayed in Figure 3. Several trends are clear. First, only one
p-value was significant based on a Bonferroni correction for 176
tests for the intercept (age-11 height). Only one SNP (rs7759938)
approached significance for the slope. This extends previous
findings for the relationship between rs7759938 and pubertal
growth [25,26]. Second, 49 (28%) SNP effects on the intercept and
77 (44%) SNP effects on the slope were in the opposite direction as
reported in the meta-analysis. A binomial test of whether the
proportion of SNPs in the opposite direction was smaller than that
expected by chance for the intercept (p=2e
29), but was chance-
level for the slope (p=.06). The QQ plot for age-11 height clearly
showed higher 2log10(p) values than expected by chance, and the
genetic score was highly significant (t=7.58, df=1652, p,1e
213).
Alternatively, the QQ plot for pubertal growth consistently
showed chance-level effects. The genetic score effect here was
nominally significant (t=2.42, df=1652, p,.004).
All regression coefficients, standard errors, and p-values for the
SNP effects on the growth model intercept, the growth model
slope, and adult height are listed in Table S1. Table S2 contains
the correlation matrix of regression coefficients from the meta-
analysis [7], the SNP effect on the growth model’s intercept and
slope, and coefficients from the analysis of adult height presented
earlier. The correlations of these regression coefficients were
statistically significant, indicating that the general trend of SNP
effects was similar across all height phenotypes. Coefficients from
the adult height analysis were correlated most strongly with the
meta-analytic coefficients (.81), followed by the SNP effects on the
intercept (.46) and slope (.17). Figure S1 is a scatterplot matrix of
these regression coefficients, illustrating the general trends of
covariance among them.
To summarize findings from the growth model, we computed
the variance in height accounted for by the genetic risk score’s
effect on the intercept and slope. A linear growth model is linear in
the mean function but quadratic in the variance. In the present
model, phenotypic height (h) is a quadratic function of the
intercept (i), slope (s), and age (a),
Var(h)~Var(i)za2Var(s)z2aCov(i,s):
This parabola was computed for the base model, with no
genetic score effect, and used to compute r
2 with the genetic score.
We plotted phenotypic r
2 in Figure 4 in green for three models: 1)
a model with a genetic score effect on the slope only, 2) a model
with a score effect on the intercept only, and 3) the full model with
a score effect simultaneously on intercept and slope. Taken
together, differences between these models allowed estimation of
the independent contribution of the genetic score on age-11 height
versus pubertal growth. Apparent in Figure 4 was that the score is
accounting for variance in height (all models including the score
result in positive and significant r
2). The model with a genetic
score effect only on the slope did account for variance in height at
all ages, but not as much as the model with a score effect only on
the intercept. More to the point, the model with score effect
simultaneously on the slope and intercept negligibly improved over
the model with score effect only on the intercept. This indicated
that the score has only a slight relationship with the unique SNP
variance in pubertal growth. However, because the score reduces
variance in height even when it was only allowed to load onto the
slope, it did appear that the score is related to genetic variance
overlapping between the intercept and slope (recall the intercept
and slope are genetically correlated at 2.56, and we expected
some genetic variants to affect both).
Using the twins, we also computed the genetic r
2, or the
genetic variance in height accounted for by the genetic score.
This is plotted in red in Figure 4 for the same three models
described in the previous paragraph. As expected, the genetic r
2
was greater than the phenotypic r
2 for the entire age range under
investigation. Comparing the maximum phenotypic r
2 to the
maximum genetic r
2 for the model with a score effect on both the
intercept and slope, one notices a jump from 9.2% (95%
c.i.=[3.0%, 15.1%]) to 14.3% (95% c.i.=[0.3%, 26%]; each
measured at the respective function’s apex). That is, by using the
twins to partition environmental variance, we were able to
increase the magnitude of the SNP effect and consequently the
sensitivity of the analysis.
Sex-Specific Analysis
Growth models were also fit separately to the male and female
subsamples. After scaling male heights for each age of assessment
to have the female’s mean and variance, the growth model
variance component parameters were different between the sexes
(x
2=78.04, df=9, p=4e
213). While heritability of the intercept
was similar (.84 for males versus .82 for females) the heritability of
the slope was different (.93 versus .64, respectively). Females had a
larger shared environmental contribution to their slope variance
(.01 for males and .31 for females). Males and females had similar
phenotypic correlations between the intercept and slope (2.66 for
males and 2.64 for females). The genetic and environmental
contributions to this correlation were different between the sexes.
The genetic correlation between intercept and slope was 2.60 for
males and 2.47 for females. The shared environment correlation
was 2.04 for males and 2.14 for females. The unshared
environmental correlation was 2.02 in males and 2.03 in females.
The overall SNP association trends were similar in both sexes
(i.e. larger effects on the intercept and smaller effects on the slope).
All SNP and score statistics are included in Table S1. Notable
differences included the following. The effect of rs7759938 on
pubertal growth is only significant for females (see Table S1). This
sex difference has been noted previously [26]. Second, as can be
seen in Figure S2, the overall genetic and phenotypic variance
accounted for in height by the score is larger for males than for
females.
Incorporating Measures of Puberty into the Growth
Model
Growth model parameters did not change dramatically after
correcting chronological ages at 11 and 14 for pubertal status. The
Developmental Approach to SNP Effects on Height
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unchanged (2.62) with a larger genetic contribution (2.58) and
smaller contributions by shared environment (2.02) and unshared
environment (2.03). The intercept was 88% heritable with
contributions of 7% and 5% from shared and unshared
environment, respectively. The slope was 84% heritable with
contributions of 10% and 6% from shared and unshared
environment, respectively.
SNP associations also remained largely unchanged after
correcting for pubertal status. Figure S3 gives association plots
for the puberty-corrected associations. The correlation between
regression weights from corrected versus uncorrected models was
very high, for associations with the intercept (r=.99) and the slope
(r=.99). The mean regression weight onto the intercept in the
uncorrected model was .06 (SD=.43) versus .05 (SD=.43). The
mean weight onto the slope in the uncorrected model was 2.005
Figure 3. SNP and Score Effects on the Growth Model Intercept and Slope. Univariate plot (a) and QQ plot (b) of SNP effects on intercept.
Univariate plot (c) and QQ plot (d) of SNP effects on the slope. All symbols are described in the caption for Figure 2. The SNP effects are relatively
stronger for age-11 height (i.e., the intercept; panels (a) and (b)) than for pubertal growth (i.e., the slope; panels (c) and (d)). The genetic score is
highly significant for age-11 height but not pubertal growth. The single Bonferroni-significant effect for the slope (highest blue dot in panels (c) and
(d)) is the only SNP, of all 180 identified in the Allen et al. [7] meta-analysis, that has been linked to pubertal growth in height [26]. All p-values are also
listed in Table S1. Each mark is colored to allow easy cross-referencing between panels, and also between Figure 2 and Figure 3.
doi:10.1371/journal.pgen.1002413.g003
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errors and p-values were equally similar between the corrected and
uncorrected models.
Discussion
The first wave of GWAS research has been successful in
identifying numerous common variants associated with various
adult disorders and traits [27]. Yet virtually all disorders and traits
are a consequence of a sequence of developmental processes, and
we know very little about how these genetic variants play out
across development. Research on FTO, where the minor allele of
rs9939609 is a well established risk-factor for adult obesity,
illustrates the importance of a developmental perspective.
Specifically, the minor allele of rs9939609 is negatively associated
with body mass index (BMI) until the age of 2.5, but, because it is
associated with an earlier onset of the adiposity rebound that
occurs in childhood, positively associated with BMI after age 5.5
years [28]. Research placing genetic association results in a
developmental context will be necessary to understand how
genetic variants contribute to a phenotype and, in the context of
disease phenotypes and personalized medicine, to determine when
and how intervention and/or prevention is possible.
The present study extended genetic analysis of developmental
phenotypes by implementing a growth model to partition observed
measures into two biologically meaningful constructs: pre-pubertal
height and pubertal growth. We focused here on an established
literature of SNP effects on height. This is necessary because
individual genetic effects are too small to be detected at genome-
wide levels by most individual studies, and combining longitudinal
studies with commensurate phenotypes can be prohibitively
difficult (longitudinal data is expensive and rare, investigators
gathering different data on individuals from different populations
at different ages and developmental levels). It may be that
consortia of cross-sectional data will largely be necessary to
discover replicable genetic variants while smaller, methodologi-
cally-unique individual studies will be left to understand those
effects within a developmental context.
The vast majority of SNPs identified by Allen et al. [7] appear
to be more strongly related to pre-pubertal height than to the
pubertal growth spurt. The sample size precludes definite
conclusions without replication or meta-analysis, however. In
addition, age is only a fallible proxy for developmental stage or
pubertal status. While many boys are expected to be pre-pubertal
at age 10.75, this is less certain for females. In the present study
15% of females had already experienced menarche by the time
Figure 4. Phenotypic and Genetic Variance in Height Accounted for by Three Models (i.e., r
2). Green indicates the r
2 of the score effect on
phenotypic variance in height (using the growth model represented in Figure 1). Red indicates the r
2 of the score effect on genetic variance in height
(using the growth model extension to twins displayed in the inset box of Figure 1). Clearly, focusing the score effect onto the twin model’s additive
genetic variance, and thereby controlling for environmental noise, allows larger estimates of r
2. Irrespective of phenotypic or genetic variance,
allowing the score to affect only the growth model slope resulted in the lowest r
2 for both conditions. Allowing the score to affect only the growth
model intercept resulted in considerable gain in r
2. Most interestingly, allowing the score to simultaneously influence the slope and intercept resulted
in negligible gain over allowing the score to influence the intercept only (i.e., the effect of score onto slope fixed at zero). This indicates that the score
is only negligibly related to genetic variation specific to pubertal growth (slope), but rather is relevant to genetic variation that affects growth
occurring up to age 11 (intercept). In addition, it provides evidence that some genetic variation indexed by the score is relevant for growth both
before age 11 and from age 11 to adulthood.
doi:10.1371/journal.pgen.1002413.g004
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status, however, the results were highly similar to those using
uncorrected ages. Nonetheless, future work evaluating genetic
effects on growth would clearly benefit from including younger
ages of assessment and more frequent follow up.
While most SNPs were unrelated to pubertal growth, one was.
rs7759938 in LIN28B has previously been identified as relevant for
adult height [7] and timingof pubertal onset [26,29,30]. Transgenic
mice in ortholog Lin28a were found to have accelerated growth
during the first 60 weeks of life in addition to later onset of puberty
[25]. Our analysis also found accelerated growth related to the G
alleleof rs7759938.However,theeffect wasnot significantformales
and was confounded with pubertal onset for females, as about 15%
ofour11-year-oldfemales had alreadyentered pubertybytheirage-
11 assessment [31]. The effect remained in females even after
adjustment for pubertal status, suggesting the variant is associated
with rate of growth during these ages. The effect remained non-
significant for males even when latergrowth periods were used as an
attempt to better measure pubertal onset (i.e., investigating growth
from age 14 to adulthood or age 17 to adulthood). The lack of an
effectformalesappearstobe asex-moderatedeffect(ref[26,30]also
reported small effects for males).
We also evaluated the effect of a genetic score on zygosity-
derived genetic variance, as opposed to phenotypic variance, using
a sample of twins. The score accounted for 14.3% of genetic
variance in adult height, but only 9.2% of phenotypic variance,
illustrating the possible advantages of using a twin sample. The use
of twins provides concrete advantages over analyses that estimate
the fraction of heritable variance attributable to multiple loci
indirectly either based on previously reported heritability estimates
or genome-wide markers in unrelated individuals. Admittedly, the
advantage may not be extremely powerful in the present context,
given height’s high heritability, where the genetic variance is 80%
or more of the total phenotypic variance. However, for less-
heritable phenotypes, or where heritability is less well known, the
approach will provide improved information about the magnitude
of a SNP’s (or gene’s, or pathway’s) relationship to the phenotype.
A growth model is not necessary to evaluate genetic r
2, but so-
called ‘‘genetically informative’’ samples such as twins or adoptive
families are. An array of statistical techniques have been developed
for such samples [15], and incorporating genetic variants like
SNPs is always possible and in many cases straightforward.
In summary, genomic findings from consortia may be fruitfully
characterized within a developmental framework. Many analytic
approaches exist, and the best may depend on the data structure at
hand. Genetically informative samples such as twins remain
important and viable tools in investigating genomic variation, even
as genotyping or sequencing becomes routine.
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Figure S1 Scatterplot Matrix of Regression Coefficients. ‘‘Meta-
Analysis’’ refers to the SNPs reported in Allen et al. [7]. ‘‘Age-11’’
Height refers to the intercept in the growth model reported in text.
‘‘Pubertal Growth’’ refers to the slope of that growth model. ‘‘Adult
Height’’referstoregressioncoefficientsfromtheadultheightanalysis.
(TIF)
Figure S2 (a) Refers to males; (b) to females. All other aspects
are described in the caption to Figure 4 in the main text.
(TIF)
Figure S3 SNP and Score Effects on the Puberty-Corrected
GrowthModelInterceptandSlope.Univariateplot(a)andQQplot
(b) of SNP effects on intercept.Univariateplot (c) and QQ plot (d) of
SNPeffectsonthe slope.Allsymbolsaredescribed inthe caption for
Figure 2. The SNP effects are relatively stronger for age-11 height
(panels (a) and (b)) than for pubertal growth (panels (c) and (d)). The
genetic score is highly significant for age-11 height but not pubertal
growth. The single Bonferroni-significant effect for the slope
(highest blue dot in panels (c) and (d)) is the only SNP, of all 180
identified intheAllenetal. [7] meta-analysis,that hasbeenlinkedto
pubertal growth in height [26]. All p-values are also listed in Table
S1. Each mark is colored to allow easy cross-referencing between
panels, and also between Figure 2 and Figure 3.
(TIF)
Table S1 Gene/allele information, regression coefficients,
standard errors, and p-values for all tests in the growth model
and the adult height analysis.
(XLS)
Table S2 Regression Correlation Coefficient Matrix. These are
Spearman rank order correlations between all 176 regression
coefficients computed for each height phenotype under study.
Confidence intervals were computed by bootstrap with 2000
pseudo-replications. ‘‘Meta-Analysis’’ refers to sex-combined
regression coefficients from the GIANT Consortium meta-analysis
[7]. ‘‘Age-11 Height’’ and ‘‘Pubertal Growth’’ are the SNP effects
on the growth model intercept and slope, respectively. ‘‘Adult
Height’’ is the full adult height analysis described in the present
report. All values are statistically significant, indicating a general
trend for the SNP effects regardless of height phenotype analyzed.
The full scatterplot matrix is given in Figure S1.
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